 | Related Articles |
Update on diffuse alveolar hemorrhage and pulmonary vasculitis.
Immunol Allergy Clin North Am. 2012 Nov;32(4):587-600
Authors: Krause ML, Cartin-Ceba R, Specks U, Peikert T
Abstract
Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.
PMID: 23102067 [PubMed - indexed for MEDLINE]